跳至主要内容
临床试验/NL-OMON30286
NL-OMON30286尚未招募不适用

TEACH survey, a prospective survey on the incidence of venous thromboembolic events during chemotherapy for solid tumors - TEACH survey (Thrombo-Embolism And Chemotherapy)

European Organisation for Research and Treatment of Cancer0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years
  • - Patients who are scheduled to receive chemotherapy of >= 3 months
  • duration for cytologically or histologically proven:
  • o breast cancer (metastatic)
  • o colorectal cancer ((neo-) adjuvant or palliative chemotherapy)
  • o gastric cancer ((neo-) adjuvant or palliative chemotherapy)
  • o lung cancer ((neo-) adjuvant or palliative chemotherapy)
  • o ovarian cancer ((neo-) adjuvant or palliative chemotherapy)
  • o pancreatic cancer ((neo-) adjuvant or palliative chemotherapy)
  • o prostate cancer (hormone-refractory)
  • - Life expectancy of more than 3 months
  • - Informed consent given by patient for data collection and
  • ultrasonography

排除标准

  • - No chemotherapy within 6 weeks before the start of the observation
  • - No major surgery including surgery for cancer within 4 weeks before the
  • start of the observation period
  • Note: minor surgery, e.g. implant of a port-a-cath, within these 4 weeks is
  • - No major surgery including surgery for cancer planned during the
  • observation period
  • Note: Radiotherapy before or during the observation period is allowed.
  • - Patients with a history of DVT or PE can be included if treatment and
  • secondary prevention of the last episode was completed prior to survey
  • - No concurrent or scheduled use of thrombo-prophylaxis or any
  • anticoagulant therapy such as parenteral anticoagulants (heparin, low
  • molecular weight heparins or other agents such as fondaparinux,
  • bivalirudin), oral anticoagulants (vitamin K antagonists) or thrombolytic

研究者

发起方
European Organisation for Research and Treatment of Cancer

相似试验